
As part of BlueRock Therapeutics vision to change the future of medicine by enabling ground-breaking cell therapies, the candidate will be a leader in the combination device development and manufacturing team responsible for ensuring that the company’s leading cell product candidates have an appropriately designed, tested and implemented combination device. Key elements include procedures to prepare and administer cell products compatible with current clinical technologies and practice of medicine, and medical device systems that safely, and accurately deliver these products to meet the unmet needs of patients with intractable diseases. The Device Development team works with leading physicians and other experts to develop clinical product procedures, delivery systems and other technologies in close partnership with our cell product development colleagues. The successful candidate is a proven team leader in the development and manufacturing of cutting-edge medical product technologies including combination medical devices and ancillary products. The ideal candidate has a deep understanding of medical device development processes and regulations, is comfortable working directly with world-renowned physicians, is highly familiar with design and manufacturing technologies and has a demonstrated track record of leading product development teams that have taken concepts and advanced them into clinical evaluation and commercial launch utilizing internal and external capabilities. Collaboration with a highly motivated, world-class team of engineers and scientists promises an exciting and engaging work environment for motivated, self-starting candidates. Proven history in developing drug delivery device development is required; experience in combination product development and surgical device development is strongly preferred.
The Director, Device Development serves as a global technical and organizational leader responsible for the end‑to‑end design, development, transfer, and clinical readiness of complex medical devices and combination products for BRT’s Cell Therapy portfolio.
This role operates beyond individual project execution, providing strategic technical leadership, cross‑functional alignment, and governance‑level decision support across Device Development, TechOps, Quality, Regulatory, Clinical, and New Product Planning organizations.
The role is a recognized authority in device design, design control, and industrialization, and functions as a primary integrator between BRT internal teams and external device partners (e.g., CDMOs, suppliers, analytical labs), ensuring clinic readiness and compliance from development through clinical studies and eventual handoff to parties responsible for commercialization.
1. Technical Leadership
2. Cross‑Functional & Matrix Leadership (No Formal Direct Reports Required)
3. Governance, Decision‑Making & Executive Interface
4. Design Control & Regulatory Stewardship
5. Industrialization, Transfer & Commercial Readiness Leadership
Impact Indicators
#LI-AL1

BlueRock Therapeutics is a clinical stage cell therapy company focused on creating cellular medicines to treat devastating diseases. We are harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, one for the treatment of Parkinson’s disease and one for the treatment of primary photoreceptor diseases, are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG that invests in paradigm-shifting breakthrough innovation. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves. For more information, visit www.bluerocktx.com.